#PharmaCannis

[holysmokescrafts]

MedMen Plunges After Scrapping PharmaCann Merger; Marijuana Stocks Slide California-based marijuana retailer MedMen (OTC:MMNFF) on Tuesday said it would terminate its merger with PharmaCann and appointed a new CFO, killing off a deal that would have made it one of the biggest cannabis companies in the U.S. MedMen stock plummeted, while Canadian marijuana stocks reclaimed gains. The announcement came a little less than a month after MedMen said the deal cleared a regulatory hurdle that moved the transaction closer to completion. The merger had been expected to close at the end of the year. MedMen was not immediately available for comment. The company reports fourth-quarter results on Oct. 28. MedMen also named Zeeshan Hyder as its new CFO, effective immediately, representing the latest turnover at the top, amid concerns about the company's spending habits. The cannabis retailer said it terminated Michael Kramer, who had served at that post, on Monday. #medmen #stocks #plunges #pharmacannis #slide #marijuanastocks #money #currency #cash #regulations #holysmokestv #holysmokes #holysmokescrafts #oneman #solo #cannabis #reform #legalization #safeaccess #news #ismokecannabis #medicalcannabis #thc #cbd #breal #massroots #rawlife #rawlife247 #losangeles #california (at Los Angeles, California) https://www.instagram.com/p/B3aV-WnBChC/?igshid=1wak6ucivatty

[sammgiraffes]

Beautiful pieces blown by Bank Glass

[cannabisbusinessexecutive]

Sprinting out of the Gate with Little Slowing Down on the Horizon: PharmaCann LLC

Sprinting out of the Gate with Little Slowing Down on the Horizon: PharmaCann LLC

After The Compassionate Use of Medical Cannabis Pilot Program Act  went into effect in January of 2014 in Illinois, Teddy Scott, founder and CEO of PharmaCann, a Ph.D. in molecular biophysics and a registered patent attorney in the law firm Polsinelli, where he focused on intellectual property issues, began discreetly working with a partner to craft a plan.

He wanted to raise capital and pursue…

[visinequeen]

We are in the midst of a health emergency in the United States, where the “opioid epidemic” is claiming upwards of 100 lives a day. Numerous new studies show that a majority of people who use marijuana are able to either reduce their use of opioids for pain or stop them altogether. During this event, we will explore how America got hooked on opiates and how cannabis is the “exit drug” out. Pamela Hadfield, Co-founder of HelloMD will open with a presentation citing recent research which will be followed by a panel of cannabis experts who have experience in reducing opiate intake using cannabis. Panelists: Rachel Schepart, RPh PharmaCannis LLC. Michelle Stormo, Brighton Health Advocates, Inc Laura Lagono, Holistic Cannabis Academy Join us. January 11th 2018 6:30-8:30pm Tickets available at www.iflw.co/wgnyc-jan18 Thank you to our sponsors, Hello MD, PharmaCannis and Galvanize NYC . . . #womenincannabis #diversityincannabis #Womengrownyc #WomenGrow #NYC #420 #dankdivas #cannabis #ladieswhoendulge #cannadivas #hemp #legalizecannabis #710 #cannamoms #maryjane  #cannapreneur #ganjagoddess #cannacurious #marijuana #canna

[werisetolegalize]

WeRiseToLegalize is Calling on Gov Cuomo to designate Medical Marijuana a Cause to Unpause. President Donald Trump should direct funds and encourage other states to create similar models. #WeRise2020 Sign the petition at: WeRise420.org Werisetolegalize.org ********************* @NYGovCuomo @CHeastie @AndreaSCousins @NBearinBomb @HealNYNow@DickGottfried @NYSenatorRivera @CannaWorld @DPA @StartSmartNY @UFCW @CitivaLLC @PalliaTechUS @VireoHealthNY @VireoHealth @ColumbiaCare @EtainLLC @PharmaCannis @ShopMedMen @SEIU1199 @NAACP @nyjusticeleague @NationalActionNet @BlkLivesMatter ‪@cannaworldsite ‬ ‪@AmeriCannaBlunt‬ @MerryJane @WhatsMyPot @CanopyGrowth @MJBizDaily @NYSA_Majority @CVHAction @VocalNewYork @1199SEIU @TWULocal100 @UFT @FollowCSA ‪@NYCPBA‬‪ @UFANY ‬@NYNurses ‪@DistCouncil37‬ ‪@TeamstersJC16‬‪ @Local831 ‬ ‪@Local237‬ ‪@NYCCOBA1‬ ‪@NYSPEF‬ ‪@DoctorsCouncil‬ ‪@CSEALocal1000‬ ‪@NYHTC‬ #Parents #Childrens #Seniors #Seizures #chronicpain #cancer #lossofappetite #cannabisoil #Albany #Harlem #Brooklyn #Queens #Bronx #Schenectady #MountVernon #Buffalo #Yonkers #Newburgh #Syracuse #NewRochelle #Rochester #Manhattan #Opioid #Methadone #cannabiscommunity #covid_19 #cure (at Harlem Hospital Center/Columbia University) https://www.instagram.com/p/B-FlWflB4dL/?igshid=n2j7v80829kh

[garudabluffs]

Massachusetts marijuana regulators OK four new retail pot shops

The first retail pot shops to open east of the Mississippi, Cultivate in Leicester and New England Treatment Access (NETA) have steadily drawn crowds.

A third retail shop, run by Alternative Therapies Group, is set to open on Saturday, Dec. 15, in Salem. It will be the first such store in eastern Massachusetts.INSA in Easthampton and Pharmacannis in Wareham, while they are in the final stage of approvals, are still waiting to the okay to commence operations.The Massachusetts Cannabis Control Commission approved four stores on Thursday, located in Hudson, Pittsfield, Great Barrington and Fall River.

The commission's votes at a meeting inside the Massachusetts State House brings the total number of retail shops that have received approvals to nine.

READ MORE https://www.masslive.com/news/index.ssf/2018/12/massachusetts_marijuana_regula_2.html

Salem marijuana retail store won't take walk-ins, says they're cash-only                                                  Dec 11,2018

“Alternative Therapies Group is also limiting purchases to one-quarter ounce of marijuana flower "until further notice." That's below the legal state limit of one ounce.

"As supply and demand in the region [stabilizes] over time, we fully intend to serve walk-in customers," the company said.”

READ MORE https://www.masslive.com/news/boston/index.ssf/2018/12/salem_marijuana_retail_store_w.html

[manostaxx]

Top Startups in Cannabis Industry

Top Startups in Cannabis Industry

[text-blocks id=”20539″ slug=”tradelabor”]

read

Startups are finding new ways to tailor innovations to cannabis businesses. Companies build digital complience solutions, data analysis tools and a host of consumer product goods.

Medical Cannabis

Companies such as PharmaCannis produce or sell marijuana intended for medicinal purposes.

Disclosed funding: $45M

Delivery/…

[westernmanews]

A second recreational pot shop could be open in western Massachusetts by the end of the week. 

The Cannabis Control Commission tweeted Monday saying they issued notices authorizing I.N.S.A. in Easthampton to commence retail operations and open in a minimum of three calendar days. 

This means the store could open as soon as Friday. 

Verilife (Pharmacannis Massachusetts, Inc.) was also issued the same notice and can open on Friday or later. 

I.N.S.A. already operates a medical marijuana dispensary at 122 Pleasant Street. That's where they will sell recreational marijuana to adults 21 and over. 

I.N.S.A and Verilife will be the fourth and fifth recreational marijuana stores to open in Massachusetts since voters legalized pot in 2016. 

NETA opened in Northampton on November 20th, making history as the first recreational pot shop to open in Western Massachusetts. 

[ccsthedon]

💣💣💨💨💨 let me get the whole box 😂🤦🏿‍♀️🤷🏾‍♂️ ➕PharmaCannis Shop #betyoucantgetinthedoor #pluggedin🔌 🚫🧢 #Aintnoaddlocationbitch😂🤣 https://www.instagram.com/p/BrIneG5A_LJQpAoasY9rfVAa_RK30g14xlyVXo0/?utm_source=ig_tumblr_share&igshid=uqss81tl9rj4

[capecoddaily]

BOSTON — A third marijuana retailer has been awarded a final license by Massachusetts regulators, but no pot shops have opened yet in the state.The Cannabis Control Commission on Thursday approved the license for Pharmacannis Massachusetts, of Wareham. The company operates a medical marijuana dispensary in the town and hopes to begin selling recreational marijuana as well.The commission earlier approved final licenses for retail sales to New England Treatment [...]

[annyleonca]

Massachusetts OKs 3rd Dispensary; No Locations Are Open Yet

BOSTON (AP) — A third marijuana retailer has been awarded a final license by Massachusetts regulators, but no dispensaries have opened yet in the state. The Cannabis Control Commission approved the license Nov. 1, 2018, for Pharmacannis Massachusetts of Wareham. The company operates a medical marijuana dispensary in the town and hopes to begin selling [...] from News About Marijuana https://www.marijuana.com/news/2018/11/massachusetts-oks-3rd-dispensary-no-locations-are-open-yet/

[garudabluffs]

Alternative Therapies Group, Inc. approved to begin recreational marijuana sales Saturday          12/11/2018

https://www.allbud.com/dispensaries/massachusetts/ma-salem/alternative-therapies-group

“Two other shops are close to opening -- INSA in Easthampton and Pharmacannis in Wareham.”

READ MORE https://www.masslive.com/news/boston/index.ssf/2018/12/alternative_therapies_group_in.html

[veriheal-blog]

The Ultimate Guide to New York Medical Marijuana

New York medical marijuana has the potential to bring in between $16.8 and $100.8 million in revenue in a single year.

Until 2017, the process for getting a medical marijuana license in New York was difficult, time-consuming and expensive. Today, it’s a lot easier to apply and access if you qualify for medical marijuana use. So how exactly do you go about doing that?

If you’re a candidate, New York medical marijuana laws aren’t too difficult to navigate. In this guide, we’ll explain all the ins and outs. After reading through this, you’ll be well on your way to getting the treatment you need.

Federal Marijuana Laws

Cannabis, in all forms, is still considered a Schedule I drug. It’s illegal under the Controlled Substances Act.

However, 29 states, including New York, now have medical cannabis laws. These laws make marijuana legal for adult medicinal use. And that number is likely to grow as more organizations and doctors get on board.

The American Public Health Association is in favor of granting access to medicinal marijuana under a doctor’s supervision. The American Cancer Society and supports research into the benefits of medical marijuana. The Federation of American Scientists is supportive as well.

The legal status of medical marijuana is likely to change in the near future. But for now, it’s still illegal at the federal level.

Recreational Marijuana Use in New York

Recreational marijuana in New York state is illegal. However, it’s been decriminalized since 1977.

Anybody caught carrying up to 25 grams of pot will result in a fine. The stipulation is that it can’t be publicly visible.

If you’re caught smoking marijuana in public, the law is different. Smoking marijuana in a public place is considered a misdemeanor and can result in a year of jail time.

Although Governor Andrew Cuomo has asked for studies to examine the effects of legalizing marijuana in New York, for now, the laws remain the same as they have been since the 1970’s.

New York Medical Marijuana Laws

The Compassionate Care Act was signed into law in July of 2014. It made New York the 23rd state to legalize marijuana for medicinal use.

Today, the program has over 50,000 patients.

It’s still illegal to grow marijuana in your own home with a medical marijuana license. It’s also illegal to smoke the marijuana flower.

How Do You Qualify for Medical Marijuana in New York?

The age requirement for qualifying for a license is 21. Those under 21 requiring a license can have a parent or legal guardian apply under their name.

Medical marijuana is available to those with the following severe or life-threatening conditions:

Cancer

HIV

AIDs

ALS (Lou Gehrig’s Disease)

Parkinson’s Disease

Multiple Sclerosis

Irritable Bowel Syndrome

Epilepsy

Huntington’s Disease

Cachexia

Post-Traumatic Stress Disorder

Spinal Cord Injury

Spasticity

Chronic pain

Neuropathy

Severe nausea

Under a July 2018 amendment, some people may be able to receive a prescription for medical marijuana as an opioid-substitute.

The process for application was difficult until 2017. In that year, a company from California began using Senate Bill 2405 to consult, assess, diagnose, educate, and treat medical marijuana patients online and through telehealth.

As a result, potential medical marijuana patients can receive a reocmmednation from a qualified physician in as little as 30 minutes.

How To Apply for New York Medical Marijuana

The first step if you’re applying for medical marijuana is to get a copy of your medical records from your regular physician. This will speed up the process of your recommendation.

To find a physician that can recommend you for medical marijuana, check the New York State Department of Health list of consenting doctors. You can set up an appointment at a physical office or you might be able to speak with them online.

If you’re a qualifying candidate, the physician will provide you with a certification. However, this isn’t enough to buy medical marijuana from a dispensary.

After receiving your certification you have to register yourself as a patient with the Medical Marijuana Program. You can do this online through the Patient Registration System.

It’s possible to have your doctor complete the registration for you. Or, you can log on to my.ny.gov and register yourself. Approval generally takes up to 10 business days.

When you receive your medical marijuana card, you’re able to buy your treatment from a legal dispensary.

Where to Buy Medical Marijuana

There are over 20 legal dispensaries in the state of New York. Some of the bigger ones include:

Columbia Care

Etain Health

Pharmacannis

Vireo Health

MedMen

It’s important to note that legal dispensaries don’t sell the marijuana for smoking. This is still considered illegal in New York state.

You can purchase capsules, oil, tinctures, topical ointment, and transdermal patches.

What Does Medical Marijuana Cost?

There are a few costs involved in getting your medical marijuana license.

The medical marijuana card itself costs $50. This application fee is non-refundable.

Your consultation with a physician will also carry a cost. Typically, consultation with consenting physicians can cost between $99 and $299.

Prices for the various forms of medical marijuana from a legal dispensary will vary depending on the dispensary, what you’re purchasing, and the variances of CBD and THC in the product.

However, the prices for New York medical marijuana are typically higher than street value. Unregulated products cost less on the black market than they do in a legal dispensary.

Can You Open Your Own Dispensary?

The dispensary business is strictly regulated in New York. Only 5 of the 43 companies that applied for certification back in 2014 were granted permission to operate.

All applicants had to pay a $10,000 application fee on top of a $200,000 deposit for consideration. They already had to have a location to dispense from, a business plan and staff before applying.

The chances of opening your own dispensary are slim. The five companies that currently operated in New York state are protective of their businesses. So much so that they sued when New York state attempted to register an additional five companies for operation.

More on Medical Marijuana

New York medical marijuana helps treat people with severe, debilitating, and life-threatening conditions that can’t find the help they desire from other treatments.

More and more states are recognizing the therapeutic benefits of cannabis for these individuals. Check out the blog for the latest news on all things medical marijuana in New York and elsewhere.

[jodieshazel]

The Anatomy of a Cannabis Trademark TTAB Decision

We’ve written (and talked) extensively about the dos and don’ts of filing cannabis-related state and federal trademarks, and we all know by now that you cannot obtain a federal trademark registration for goods or services that are not lawful pursuant to federal law. But I’ve heard a lot of creative arguments in this space, and have had many clients indicate an interest in challenging the status quo at the United States Patent and Trademark Office (USPTO).

Unfortunately (or fortunately, depending on how you look at it), the Trademark Trial and Appeals Board (TTAB) has handed down numerous opinions of precedent that lay forth the USPTO’s position on the “lawful use in commerce” requirement in detail. In this post, I thought it would be useful to breakdown the TTAB’s analysis on this issue via their In re PharmaCann LLC opinion, which was issued in June of 2017.

No lawful use in commerce = no trademark.

In the PharmaCann case, the Applicant sought registration of two trademarks: PHARMACANN and PHARMACANNIS, both for “retail store services featuring medical marijuana,” in International Class 35, and “dispensing of pharmaceuticals featuring medical marijuana,” in International Class 44. The Examining Attorney refused registration of both marks pursuant to Sections 1 and 45 of the Trademark Act, 15 U.S.C. §§ 1051 and 1127, on the ground that Applicant could not allege a bona fide intent to make lawful use of the marks in commerce because the services identified involved the distribution and dispensing of cannabis, which is a controlled substance whose distribution and dispensing are illegal under the federal Controlled Substances Act (CSA), 21 U.S.C. §§ 801 et seq..

In its opinion, the TTAB pointed out that it has “consistently held that, to qualify for a federal … registration, the use of a mark in commerce must be ‘lawful’.” In re JJ206, LLC, 120 USPQ2d 1568, 1569 (TTAB 2016) (affirming refusal to register POWERED BY JUJU and JUJU JOINTS for cannabis vaporizing and delivery services for lack of lawful use in commerce). The TTAB further elaborated that for a mark to be eligible for federal registration, “any goods or services for which the mark is used must not be illegal under federal law.” In re Brown, 119 USPQ2d 1350, 1351 (TTAB 2016). And even if an Applicant files on an intent-to-use basis (meaning they intend to use the mark in commerce in the near future but have not done so yet), if the identified goods or services with which the mark is intended to be used are illegal under federal law, “the applicant cannot use its mark in lawful commerce, ad it is a legal impossibility for the applicant to have the requisite bona fide intent to use the mark.” JJ206, 120 USPQ2d at 1569.

In general, registration will not be refused for lack of lawful use in commerce unless either “(1) a violation of federal law is indicated by the application or other evidence …, or (2) when the applicant’s application-related activities involve a per se violation of a federal law.” Brown, 119 USPQ2d at 1351. In the case at hand, the TTAB deemed the Applicant’s marijuana distribution and dispensing activities to be a per se violation of the CSA. The analysis here was pretty straightforward, where the CSA prohibits, among other things, manufacturing, distributing, or dispensing controlled substances (21 U.S.C. § 841(a)(1)), and where marijuana is a Schedule I controlled substance under the CSA. 21 U.S.C. § 812(c) Schedule I (c)(10).

The Applicant here made two arguments in opposition to the TTAB’s position. The first argument was that “[s]ince 2009 the Department of Justice has consistently refused to treat medical marijuana as an illegal drug by consistently refusing to enforce the Controlled Substances Act against it.” In making its argument regarding the federal government’s lack of enforcement against medical marijuana businesses operating in compliance with state law, the Applicant relied on the (now rescinded) Cole Memorandum. But the TTAB clarified that it had previously decided in JJ206 that the Cole Memorandum “provides no support for the registration of a trademark used on goods whose sale is illegal under federal law,” and that this determination applied with equal force to the Applicant in this case’s intended use of its marks for distributing and dispensing medical marijuana.

The Applicant’s second, and more novel, argument was that “Congress has taken the same position as the Department of Justice,” because in the Consolidated and Further Continuing Appropriations Act of 2015 (as renewed in the Consolidated Appropriations Act of 2016, subsequent continuing resolutions, and in the Consolidated Appropriations Act of 2017), Congress has prohibited the Department of Justice from utilizing funds to prevent states that have legalized medical marijuana from implementing their own state laws authorizing the use, distribution, possession, or cultivation of medical marijuana. The Applicant’s argument was that Congress’ decision not to fund the DOJ to enforce the CSA against medical marijuana, “it would make no sense and serve no purpose for the Board to take a different position…”.

The TTAB, however, found this second argument equally lacking, and relied on United States v. McIntosh (833 F.3d 1163, 1169-70 (9th Cir. 2016)) for its analysis. In that case, the court concluded that the Appropriations Acts and the Rohrabacher-Farr Amendment did not make medical marijuana legal under the CSA. The TTAB applied that conclusion to the case at hand and rejected the Applicant’s argument.

These TTAB opinions are instructive in that they give us a clear view into how the USPTO is lawful use in commerce requirement; although the legal status of cannabis and particularly the federal government’s enforcement efforts remain murky, so long as marijuana remains a Schedule I controlled substance, federal trademark protection will not be available.

For other posts on cannabis trademarks, check out the following:

Revisiting the Basics of Federal Trademarks in the Cannabis Industry

Yet ANOTHER Cannabis Trademark Infringement Case: Tapatio Foods Files Suit

What NOT to do with your Cannabis Brand: The Gorilla Glue Trademark Infringement Dispute

Another Cannabis Trademark Application Bites the Dust

Cannabis Trademarks: The Importance of Monitoring Your Brand

from Canna Law Blog™ https://www.cannalawblog.com/the-anatomy-of-a-cannabis-trademark-ttab-decision/

[capecoddaily]

After three years of planning and development, a medical cannabis dispensary will open in Wareham this May. Recreational sales are scheduled to start in July, provided the state’s timeline remains unchanged, according to officials from Pharmacannis Massachusetts, Inc. Located at 112 Main St., the facility will provide information and consultations for both medical and recreational (or “adult use”) customers. “We ...

[needhiredus]

State law requires that applicants be 21 years old and over. PharmaCann, LLC provides equal employment opportunities (EEO) to all employees and applicants for…

via NeedHired